| American Sales Company Children’s Allergy Relief Drug Facts | Product name | American Sales Company | 2026-11-06 |
| Kroger Co. Nicotine Lozenge Drug Facts | Product name | Kroger Company | 2026-11-06 |
| These highlights do not include all the information needed to use DIVALPROEX SODIUM EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DIVALPROEX SODIUM EXTENDED-RELEASE TABLETS. DIVALPROEX SODIUM extended-release tablets, for oral use Initial U.S. Approval: 2000 | Product name | Bryant Ranch Prepack | 2026-11-06 |
| Costco Wholesale Corp. Nicotine Polacrilex Lozenge 4 mg Drug Facts | Product name | Costco Wholesale Company | 2026-11-05 |
| These highlights do not include all the information needed to use AMOXICILLIN TABLETS (CHEWABLE), safely and effectively. See full prescribing information for AMOXICILLIN TABLETS (CHEWABLE). AMOXICILLIN tablets (chewable), for oral use Initial U.S. Approval: 1974 | Product name | PD-Rx Pharmaceuticals, Inc. | 2026-11-05 |
| These highlights do not include all the information needed to use CLOPIDOGREL TABLETS safely and effectively. See full prescribing information for CLOPIDOGREL TABLETS. CLOPIDOGREL tablets, for oral use Initial U.S. Approval: 1997 | Product name | PD-Rx Pharmaceuticals, Inc. | 2026-11-05 |
| Cetirizine Hydrochloride Tablets | Product name | Care One (Retail Business Services, LLC.) | 2026-11-04 |
| Cold + Flu Relief Orange Chewables | Product name | Schwabe North America, Inc. | Thermo-Pak Company, Inc. | 2026-11-04 |
| Cold Relief Kids Cherry 30 chew tabs | Product name | Schwabe North America, Inc | Schwabe North America, Inc. | Thermo-Pak Company, Inc. | 2026-11-04 |
| These highlights do not include all the information needed to use EZETIMIBE TABLETS safely and effectively. See full prescribing information for EZETIMIBE TABLETS. EZETIMIBE tablets, for oral use Initial U.S. Approval: 2002 | Product name | Marlex Pharmaceuticals, Inc. | 2026-11-04 |
| These highlights do not include all the information needed to use LYTGOBI safely and effectively. See full prescribing information for LYTGOBI. LYTGOBI ® (futibatinib) tablets, for oral use Initial U.S. Approval: 2022 | Product name | TAIHO PHARMACEUTICAL CO., LTD. | 2026-11-04 |
| These highlights do not include all the information needed to use CLOPIDOGREL TABLETS safely and effectively. See full prescribing information for CLOPIDOGREL TABLETS. CLOPIDOGREL tablets, for oral use Initial U.S. Approval: 1997 | Product name | PD-Rx Pharmaceuticals, Inc. | 2026-11-03 |
| These highlights do not include all the information needed to use SEVELAMER HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for SEVELAMER HYDROCHLORIDE TABLETS. SEVELAMER HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 2000 | Product name | Glenmark Pharmaceuticals Inc., USA | Glenmark Pharmaceuticals Limited | 2026-11-03 |
| Costco Wholesale Corp. Quit 2 Drug Facts | Product name | Costco Wholesale Company | 2026-11-02 |
| OSCIMIN Sublingual Tablets | Product name | Larken Laboratories, Inc. | 2026-11-02 |
| Wal-Mart Nicotine Lozenges Drug Facts | Product name | Wal-Mart Stores Inc | 2026-11-01 |
| Wal-Mart Nicotine Lozenges Drug Facts | Product name | Wal-Mart Stores Inc | 2026-11-01 |
| These highlights do not include all the information needed to use ADZYNMA safely and effectively. See full prescribing information for ADZYNMA. ADZYNMA (ADAMTS13, recombinant-krhn) lyophilized powder for Injection, for intravenous use Initial U.S. Approval: 2023 | Product name | TAKEDA PHARMACEUTICALS AMERICA, INC. | Takeda Manufacturing Singapore Pte Ltd | Takeda Manufacturing Austria AG | SGS Lab Simon | BioReliance Ltd | Sigma-Aldrich Pte Ltd | Shire Human Genetic Therapies Inc. | Charles River Laboratories Germany GmbH | OFI Technologie & Innovation GmbH | Siegfried Hameln GmbH | Hameln RDS | 2026-10-30 |
| Simulect ® (basiliximab) For Injection Rx only Prescribing Information | Product name | Novartis Pharmaceuticals Corporation | 2026-10-26 |
| These highlights do not include all the information needed to use AUGMENTIN safely and effectively. See full prescribing information for AUGMENTIN. Augmentin (amoxicillin and clavulanate potassium) for oral suspension Initial U.S. Approval: 1984 | Product name | Allegis Holdings, LLC | 2026-10-26 |
| These highlights do not include all the information needed to use GLATOPA safely and effectively. See full prescribing information for GLATOPA . GLATOPA ® (glatiramer acetate injection), for subcutaneous use Initial U.S. Approval: 1996 | Product name | Bryant Ranch Prepack | 2026-10-26 |
| These highlights do not include all the information needed to use GLATOPA safely and effectively. See full prescribing information for GLATOPA . GLATOPA ® (glatiramer acetate injection), for subcutaneous use Initial U.S. Approval: 1996 | Product name | Bryant Ranch Prepack | 2026-10-26 |
| These highlights do not include all the information needed to use TELMISARTAN AND AMLODIPINE TABLETS safely and effectively. See full prescribing information for TELMISARTAN AND AMLODIPINE TABLETS. TELMISARTAN and AMLODIPINE tablets, for oral use Initial U.S. Approval: 2009 | Product name | Alembic Pharmaceuticals Limited | 2026-10-26 |
| These highlights do not include all the information needed to use LENALIDOMIDE CAPSULES safely and effectively. See full prescribing information for LENALIDOMIDE CAPSULES. LENALIDOMIDE capsules, for oral use Initial U.S. Approval: 2005 | Product name | Novugen Pharma (USA) LLC | Novugen Oncology Sdn. Bhd. | Novugen Oncology Sdn Bhd | 2026-10-23 |
| These highlights do not include all the information needed to use ASENAPINE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for ASENAPINE SUBLINGUAL TABLETS. ASENAPINE sublingual tablets Initial U.S. Approval: 2009 | Product name | Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited | 2026-10-22 |
| These highlights do not include all the information needed to use RAPIBLYK ® safely and effectively. See full prescribing information for RAPIBLYK. RAPIBLYK (landiolol) for injection, for intravenous use Initial U.S. Approval: 2024 | Product name | AOP Orphan Pharmaceuticals GmbH | 2026-10-19 |
| These highlights do not include all the information needed to use LURASIDONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for LURASIDONE HYDROCHLORIDE TABLETS. LURASIDONE hydrochloride tablets, for oral use Initial U.S. Approval: 2010 | Product name | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2026-10-16 |
| These highlights do not include all the information needed to use MATULANE safely and effectively. See full prescribing information for MATULANE. MATULANE (procarbazine hydrochloride) capsules, for oral use Initial U.S. Approval: 1969 | Product name | Leadiant Biosciences, Inc. | 2026-10-09 |
| These highlights do not include all the information needed to use ATORVASTATIN CALCIUM TABLETS safely and effectively. See full prescribing information for ATORVASTATIN CALCIUM TABLETS. ATORVASTATIN CALCIUM tablets, for oral use Initial U.S. Approval: 1996 | Product name | Radha Pharmaceuticals, Inc. | ScieGen Pharmaceuticals, Inc. | 2026-10-08 |
| These highlights do not include all the information needed to use ORGOVYX safely and effectively. See full prescribing information for ORGOVYX. ORGOVYX (relugolix) tablets, for oral use Initial U.S. Approval: 2020 | Product name | Sumitomo Pharma America, Inc. | 2026-10-08 |
| Drug Facts | Product name | Harris Teeter, LLC | 2026-10-06 |
| Pepto Bismol ® CHEWABLES | Product name | Procter & Gamble Manufactura S de RL de CV | 2026-10-05 |
| Pepto Bismol ® CHEWABLES | Product name | Procter & Gamble Manufactura S de RL de CV | 2026-10-05 |
| POCKET PEPTO Pepto Bismol ® Bismuth Subsalicylate Upset Stomach Reliever/Antidiarrheal CHEWABLES CHERRY | Product name | Procter & Gamble Manufactura S de RL de CV | 2026-10-05 |
| These highlights do not include all the information needed to use TROKENDI XR ® safely and effectively. See full prescribing information for TROKENDI XR ® . TROKENDI XR ® (topiramate) extended-release capsules, for oral use Initial U.S. Approval: 1996 | Product name | Supernus Pharmaceuticals, Inc. | 2026-10-05 |
| Lisinopril and Hydrochlorothiazide Tablets, USP, for oral use Rx Only | Product name | St. Mary's Medical Park Pharmacy | 2026-10-01 |
| These highlights do not include all the information needed to use ONDANSETRON ORALLY DISINTEGRATING TABLETS, safely and effectively. See full prescribing information for ONDANSETRON ORALLY DISINTEGRATING TABLETS. ONDANSETRON orally disintegrating tablets Initial U.S. Approval: 1991 | Product name | Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM | 2026-10-01 |
| Equate 44-450 | Product name | Wal-Mart Stores Inc | LNK International, Inc. | 2026-09-29 |
| Topco Associates LLC. Nicotine Polacrilex Lozenge 2 mg (nicotine) Drug Facts | Product name | Topco Associates LLC | 2026-09-29 |
| Walgreen Co. Nicotine Lozenge Drug Facts | Product name | Walgreen Company | 2026-09-29 |
| These highlights do not include all the information needed to use ADZYNMA safely and effectively. See full prescribing information for ADZYNMA. ADZYNMA (ADAMTS13, recombinant-krhn) lyophilized powder for Injection, for intravenous use Initial U.S. Approval: 2023 | Product name | TAKEDA PHARMACEUTICALS AMERICA, INC. | Takeda Manufacturing Singapore Pte Ltd | Takeda Manufacturing Austria AG | SGS Lab Simon | BioReliance Ltd | Sigma-Aldrich Pte Ltd | Shire Human Genetic Therapies Inc. | Charles River Laboratories Germany GmbH | OFI Technologie & Innovation GmbH | Siegfried Hameln GmbH | Hameln RDS | 2026-09-25 |
| These highlights do not include all the information needed to use WELIREG safely and effectively. See full prescribing information for WELIREG. WELIREG ® (belzutifan) tablets, for oral use Initial U.S. Approval: 2021 | Product name | Merck Sharp & Dohme LLC | 2026-09-24 |
| These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993 | Product name | Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM | 2026-09-23 |
| These highlights do not include all the information needed to use UNLOXCYT safely and effectively. See full prescribing information for UNLOXCYT. UNLOXCYT ® (cosibelimab-ipdl) injection, for intravenous use Initial U.S. Approval: 2024 | Product name | Sun Pharmaceutical Industries, Inc. | 2026-09-21 |
| Wal-Mart Nicotine Gum Drug Facts | Product name | Wal-Mart Stores Inc | 2026-09-21 |
| These highlights do not include all the information needed to use RITONAVIR TABLETS safely and effectively. See full prescribing information for RITONAVIR TABLETS. RITONAVIR tablets, for oral use Initial U.S. Approval: 1996 | Product name | Aurobindo Pharma Limited | 2026-09-17 |
| These highlights do not include all the information needed to use TROKENDI XR ® safely and effectively. See full prescribing information for TROKENDI XR ® . TROKENDI XR ® (topiramate) extended-release capsules, for oral use Initial U.S. Approval: 1996 | Product name | Supernus Pharmaceuticals, Inc. | 2026-09-15 |
| These highlights do not include all the information needed to use ELTROMBOPAG TABLETS safely and effectively. See full prescribing information for ELTROMBOPAG TABLETS. ELTROMBOPAG tablets, for oral use Initial U.S. Approval: 2008 | Product name | Hikma Pharmaceuticals USA Inc. | Zenara Pharma Private Limited | 2026-09-11 |
| BJWC Omeprazole Drug Facts | Product name | BJWC | 2026-09-10 |
| These highlights do not include all the information needed to use GLATIRAMER ACETATE INJECTION safely and effectively. See full prescribing information for GLATIRAMER ACETATE INJECTION. GLATIRAMER ACETATE injection, for subcutaneous use Initial U.S. Approval: 1996 | Product name | AJENAT PHARMACEUTICALS LLC | Guangdong Sunshine Pharmaceutical Co Ltd | 2026-09-10 |
| These highlights do not include all the information needed to use XARELTO safely and effectively. See full prescribing information for XARELTO. XARELTO ® (rivaroxaban) tablets, for oral use XARELTO ® (rivaroxaban) for oral suspension Initial U.S. Approval: 2011 | Product name | Janssen Pharmaceuticals, Inc. | AndersonBrecon Inc. | Patheon, Inc. | Bayer AG | Bayer Aktiengesellschaft | LUSOMEDICAMENTA - SOCIEDADE TÉCNICA FARMACÊUTICA, S.A. | Johnson & Johnson Private Limited | Janssen Ortho LLC | Janssen Pharmaceuticals Inc. | 2026-09-10 |
| Walgreen Co. Nicotine Mini Lozenge Drug Facts | Product name | Walgreen Company | 2026-09-10 |
| Rite Aid Corporation Nicotine Lozenge Drug Facts | Product name | Rite Aid Corporation | 2026-09-09 |
| These highlights do not include all the information needed to use LEVOTHYROXINE SODIUM TABLETS safely and effectively. See full prescribing information for LEVOTHYROXINE SODIUM TABLETS. LEVOTHYROXINE SODIUM tablets, for oral use Initial U.S. Approval: 2002 | Product name | REMEDYREPACK INC. | 2026-09-09 |
| These highlights do not include all the information needed to use PRAMIPEXOLE DIHYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for PRAMIPEXOLE DIHYDROCHLORIDE TABLETS. PRAMIPEXOLE DIHYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1997 | Product name | A-S Medication Solutions | 2026-09-09 |
| Telmisartan and Hydrochlorothiazide tablets, for oral use These highlights do not include all the information needed to use TELMISARTAN AND HYDROCHLOROTHIAZIDE TABLETS safely and effectively. See full prescribing information for TELMISARTAN AND HYDROCHLOROTHIAZIDE TABLETS. Initial U.S. Approval: 2000 | Product name | AvKARE | 2026-09-08 |
| These highlights do not include all the information needed to use RIZATRIPTAN BENZOATE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for RIZATRIPTAN BENZOATE ORALLY DISINTEGRATING TABLETS. RIZATRIPTAN BENZOATE orally disintegrating tablets, for oral use Initial U.S. Approval: 1998 | Product name | REMEDYREPACK INC. | 2026-09-08 |
| Goodys Max Relief Tropical Citrus | Product name | Medtech Products Inc. | 2026-09-03 |
| These highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993 | Product name | REMEDYREPACK INC. | 2026-09-01 |
| These highlights do not include all the information needed to use MOVANTIK safely and effectively. See full prescribing information for MOVANTIK. MOVANTIK ® (naloxegol) tablets, for oral use Initial U.S. Approval: 2014 | Product name | Averitas Pharma, Inc. | 2026-09-01 |
| These highlights do not include all the information needed to use BONSITY safely and effectively. See full prescribing information for BONSITY. BONSITY (teriparatide injection), for subcutaneous use Initial U.S. Approval: 1987 | Product name | Alvogen Inc. | 2026-08-31 |
| These highlights do not include all the information needed to use KRAZATI safely and effectively. See full prescribing information for KRAZATI. KRAZATI ® (adagrasib) tablets, for oral use Initial U.S. Approval: 2022 | Product name | Mirati Therapeutics, Inc | 2026-08-31 |
| These highlights do not include all the information needed to use TERIPARATIDE INJECTION safely and effectively. See full prescribing information for TERIPARATIDE INJECTION. TERIPARATIDE injection, for subcutaneous use Initial U.S. Approval: 1987 | Product name | Alvogen, Inc. | 2026-08-31 |
| These highlights do not include all the information needed to use ONDANSETRON ORALLY DISINTEGRATING TABLETS, safely and effectively. See full prescribing information for ONDANSETRON ORALLY DISINTEGRATING TABLETS. ONDANSETRON orally disintegrating tablets Initial U.S. Approval: 1991 | Product name | Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM | 2026-08-28 |
| These highlights do not include all the information needed to use AQVESME safely and effectively. See full prescribing information for AQVESME . AQVESME ™ ( mitapivat ) tablets for oral use Initial U.S. Approval: 2022 | Product name | Agios Pharmaceuticals, Inc. | 2026-08-27 |
| These highlights do not include all the information needed to use CLOPIDOGREL TABLETS safely and effectively. See full prescribing information for CLOPIDOGREL TABLETS. CLOPIDOGREL tablets, for oral use Initial U.S. Approval: 1997 | Product name | REMEDYREPACK INC. | 2026-08-27 |
| These highlights do not include all the information needed to use TICAGRELOR TABLETS safely and effectively. See full prescribing information for TICAGRELOR TABLETS. TICAGRELOR tablets, for oral use Initial U.S. Approval: 2011 | Product name | Teva Pharmaceuticals, Inc. | 2026-08-27 |
| Aurohealth LLC | APL HEALTHCARE LIMITED human otc drug label | Product name | Aurohealth LLC | APL HEALTHCARE LIMITED | 2026-08-25 |
| These highlights do not include all the information needed to use ALOGLIPTIN AND METFORMIN HCl TABLETS safely and effectively. See full prescribing information for ALOGLIPTIN AND METFORMIN HCl TABLETS. Alogliptin and Metformin Hydrochloride Tablets, for oral use Initial U.S. Approval: 2013 | Product name | Padagis Israel Pharmaceuticals Ltd | 2026-08-25 |
| These highlights do not include all the information needed to use ADZYNMA safely and effectively. See full prescribing information for ADZYNMA. ADZYNMA (ADAMTS13, recombinant-krhn) lyophilized powder for Injection, for intravenous use Initial U.S. Approval: 2023 | Product name | TAKEDA PHARMACEUTICALS AMERICA, INC. | Takeda Manufacturing Singapore Pte Ltd | Takeda Manufacturing Austria AG | SGS Lab Simon | BioReliance Ltd | Sigma-Aldrich Pte Ltd | Shire Human Genetic Therapies Inc. | Charles River Laboratories Germany GmbH | OFI Technologie & Innovation GmbH | Siegfried Hameln GmbH | Hameln RDS | 2026-08-20 |
| These highlights do not include all the information needed to use YERVOY safely and effectively. See full prescribing information for YERVOY. YERVOY ® (ipilimumab) injection, for intravenous use Initial U.S. Approval: 2011 | Product name | E.R. Squibb & Sons, L.L.C. | 2026-08-20 |
| These highlights do not include all the information needed to use GLATIRAMER ACETATE INJECTION safely and effectively. See full prescribing information for GLATIRAMER ACETATE INJECTION. GLATIRAMER ACETATE injection, for subcutaneous use Initial U.S. Approval: 1996 | Product name | Zydus Pharmaceuticals USA Inc. | Italfarmaco SpA | 2026-08-19 |
| These highlights do not include all the information needed to use UNLOXCYT safely and effectively. See full prescribing information for UNLOXCYT. UNLOXCYT ® (cosibelimab-ipdl) injection, for intravenous use Initial U.S. Approval: 2024 | Product name | Sun Pharmaceutical Industries, Inc. | 2026-08-19 |
| These highlights do not include all the information needed to use INDOMETHACIN EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for INDOMETHACIN EXTENDED-RELEASE CAPSULES. INDOMETHACIN extended-release capsules, for oral use Initial U.S. Approval: 1965 | Product name | Sportpharm LLC | 2026-08-17 |
| These highlights do not include all the information needed to use PRAVASTATIN SODIUM TABLETS safely and effectively. See full prescribing information for PRAVASTATIN SODIUM TABLETS. PRAVASTATIN SODIUM tablets, for oral use Initial U.S. Approval: 1991 | Product name | Preferred Pharmaceuticals Inc. | 2026-08-17 |
| These highlights do not include all the information needed to use VENLAFAXINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for VENLAFAXINE EXTENDED-RELEASE TABLETS. VENLAFAXINE extended-release tablets, for oral use Initial U.S. Approval: 1993 | Product name | REMEDYREPACK INC. | 2026-08-17 |
| These highlights do not include all the information needed to use MIRCERA safely and effectively. See full prescribing information for MIRCERA. MIRCERA ® (methoxy polyethylene glycol-epoetin beta) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2007 | Product name | Vifor (International) Inc. | Roche Diagnostics GmbH | F. Hoffmann-La Roche Ltd | 2026-08-14 |
| These highlights do not include all the information needed to use DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION. DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 1998 | Product name | Aurobindo Pharma Limited | EUGIA PHARMA SPECIALITIES LIMITED | 2026-08-13 |
| Drug Facts | Product name | WALMART INC. (see also Equate) | 2026-08-12 |
| Rite Aid 44-450 Childrens | Product name | Rite Aid Corporation | LNK International, Inc. | 2026-08-11 |
| These highlights do not include all the information needed to use YEZTUGO safely and effectively. See full prescribing information for YEZTUGO. YEZTUGO ® (lenacapavir) tablets, for oral use YEZTUGO ® (lenacapavir) injection, for subcutaneous use Initial U.S. Approval: 2022 | Product name | Gilead Sciences, Inc. | 2026-08-11 |
| Dye-Free Children's Loratadine | Product name | CVS PHARMACY, INC | Ohm Laboratories Inc. | 2026-08-05 |
| These highlights do not include all the information needed to use TICAGRELOR TABLETS safely and effectively. See full prescribing information for TICAGRELOR TABLETS. TICAGRELOR tablets, for oral use Initial U.S. Approval: 2011 | Product name | Teva Pharmaceuticals, Inc. | 2026-08-05 |
| These highlights do not include all the information needed to use RABEPRAZOLE SODIUM DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for RABEPRAZOLE SODIUM DELAYED-RELEASE TABLETS. RABEPRAZOLE SODIUM delayed-release tablets, for oral use Initial U.S. Approval: 1999 | Product name | REMEDYREPACK INC. | 2026-08-04 |
| DOXYCYCLINE FOR INJECTION, USP Rx Only | Product name | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | 2026-08-03 |
| These highlights do not include all the information needed to use Elitek safely and effectively. See full prescribing information for Elitek ® . ELITEK (rasburicase) for injection, for intravenous use Initial U.S. Approval: 2002 | Product name | Sanofi-Aventis U.S. LLC | Sanofi Winthrop Industrie | Sanofi S.r.l. | 2026-07-30 |
| These highlights do not include all the information needed to use CASPOFUNGIN ACETATE FOR INJECTION safely and effectively. See full prescribing information for CASPOFUNGIN ACETATE FOR INJECTION. CASPOFUNGIN ACETATE for injection, for intravenous use Initial U.S. Approval: 2001 | Product name | Sagent Pharmaceuticals | 2026-07-29 |
| These highlights do not include all the information needed to use ONDANSETRON TABLETS and ONDANSETRON ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for ONDANSETRON TABLETS and ONDANSETRON ORALLY DISINTEGRATING TABLETS. ONDANSETRON tablets, for oral use ONDANSETRON orally disintegrating tablets Initial U.S. Approval: 1991 | Product name | A-S Medication Solutions | 2026-07-29 |
| LURASIDONE HYDROCHLORIDE TABLETS. These highlights do not include all the information needed to use LURASIDONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for LURASIDONE HYDROCHLORIDE TABLETS. LURASIDONE hydrochloride tablets, for oral use Initial U.S. Approval: 2010 | Product name | Golden State Medical Supply, Inc. | 2026-07-28 |
| These highlights do not include all the information needed to use MONTELUKAST SODIUM safely and effectively. See full prescribing information for MONTELUKAST SODIUM. MONTELUKAST SODIUM tablets, for oral use MONTELUKAST SODIUM chewable tablets, for oral use Initial U.S. Approval: 1998 | Product name | Preferred Pharmaceuticals Inc. | 2026-07-28 |
| These highlights do not include all the information needed to use PREGABALIN CAPSULES safely and effectively. See full prescribing information for PREGABALIN CAPSULES. PREGABALIN Capsules, CV Initial U.S. Approval: 2004 | Product name | REMEDYREPACK INC. | 2026-07-28 |
| These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002 | Product name | REMEDYREPACK INC. | 2026-07-27 |
| These highlights do not include all the information needed to use RABEPRAZOLE SODIUM DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for RABEPRAZOLE SODIUM DELAYED-RELEASE TABLETS. RABEPRAZOLE SODIUM delayed-release tablets, for oral use Initial U.S. Approval: 1999 | Product name | Torrent Pharmaceuticals Limited | Torrent Pharma, Inc. | 2026-07-27 |
| These highlights do not include all the information needed to use Elitek safely and effectively. See full prescribing information for Elitek ® . ELITEK (rasburicase) for injection, for intravenous use Initial U.S. Approval: 2002 | Product name | Sanofi-Aventis U.S. LLC | Sanofi Winthrop Industrie | Sanofi S.r.l. | 2026-07-24 |
| These highlights do not include all the information needed to use ICOSAPENT ETHYL CAPSULES safely and effectively. See full prescribing information for ICOSAPENT ETHYL CAPSULES. ICOSAPENT ETHYL capsules, for oral use Initial U.S. Approval: 2012 | Product name | Dr. Reddy's Laboratories, Inc. | 2026-07-22 |
| Drug Facts | Product name | P & L Development, LLC | 2026-07-21 |
| These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988 | Product name | Aurobindo Pharma Limited | APL HEALTHCARE LIMITED | 2026-07-21 |
| These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993 | Product name | REMEDYREPACK INC. | 2026-07-17 |
| These highlights do not include all the information needed to use LAMOTRIGINE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE ORALLY DISINTEGRATING TABLETS. LAMOTRIGINE orally disintegrating tablets, for oral use Initial U.S. Approval: 1994 | Product name | Torrent Pharmaceuticals Limited | 2026-07-17 |
| These highlights do not include all the information needed to use LINEZOLID for Oral Suspension safely and effectively. See full prescribing information for LINEZOLID for Oral Suspension. LINEZOLID for oral suspension Initial U.S. Approval: 2000 | Product name | Hikma Pharmaceuticals USA Inc. | West-Ward Columbus Inc. | 2026-07-17 |
| WinCo 44-585 Delisted | Product name | WinCo Foods, LLC | LNK International, Inc. | 2026-07-17 |
| Drug Facts | Product name | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 2026-07-16 |
| These highlights do not include all the information needed to use DICLOFENAC POTASSIUM FOR ORAL SOLUTION safely and effectively. See full prescribing information for DICLOFENAC POTASSIUM FOR ORAL SOLUTION . DICLOFENAC POTASSIUM, for oral solution Initial U.S. Approval: 1988 | Product name | Par Health USA, LLC | 2026-07-16 |
| These highlights do not include all the information needed to use VOQUEZNA ® safely and effectively. See full prescribing information for VOQUEZNA. VOQUEZNA (vonoprazan) tablets, for oral use Initial U.S. Approval: 2022 | Product name | Phathom Pharmaceuticals Inc. | 2026-07-16 |
| These highlights do not include all the information needed to use VOQUEZNA ® TRIPLE PAK ® and VOQUEZNA ® DUAL PAK ® safely and effectively. See full prescribing information for VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK. VOQUEZNA TRIPLE PAK (vonoprazan tablets; amoxicillin capsules; clarithromycin tablets), co-packaged for oral use VOQUEZNA DUAL PAK (vonoprazan tablets; amoxicillin capsules) co-packaged for oral use Initial U.S. Approval: 2022 | Product name | Phathom Pharmaceuticals Inc. | Sandoz GmbH | 2026-07-16 |
| MEDERMA PM DRUG FACTS | Product name | PMI Branded Pharmaceuticals, Inc. | 2026-07-15 |
| These highlights do not include all the information needed to use FLUOXETINE TABLETS safely and effectively. See full prescribing information for FLUOXETINE TABLETS. FLUOXETINE tablets, for oral use Initial U.S. Approval: 1987 | Product name | Aurobindo Pharma Limited | APL HEALTHCARE LIMITED | 2026-07-15 |
| These highlights do not include all the information needed to use LINEZOLID for Oral Suspension safely and effectively. See full prescribing information for LINEZOLID for Oral Suspension. LINEZOLID for oral suspension Initial U.S. Approval: 2000 | Product name | Hikma Pharmaceuticals USA Inc. | West-Ward Columbus Inc. | 2026-07-15 |
| Costco Wholesale Corp. Quit 2 Drug Facts | Product name | Costco Wholesale Company | 2026-07-14 |
| These highlights do not include all the information needed to use LURASIDONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for LURASIDONE HYDROCHLORIDE TABLETS. LURASIDONE hydrochloride tablets, for oral use Initial U.S. Approval: 2010 | Product name | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc. | 2026-07-14 |
| These highlights do not include all the information needed to use ROSUVASTATIN TABLETS safely and effectively. See full prescribing information for ROSUVASTATIN TABLETS. ROSUVASTATIN tablets, for oral use Initial U.S. Approval: 2003 | Product name | REMEDYREPACK INC. | 2026-07-14 |
| These highlights do not include all the information needed to use ZOLEDRONIC ACID INJECTION safely and effectively. See full prescribing information for ZOLEDRONIC ACID INJECTION. ZOLEDRONIC ACID injection, for intravenous infusion Initial U.S. Approval: 2001 | Product name | Sagent Pharmaceuticals | 2026-07-14 |
| These highlights do not include all the information needed to use ICOSAPENT ETHYL CAPSULES safely and effectively. See full prescribing information for ICOSAPENT ETHYL CAPSULES. ICOSAPENT ETHYL capsules, for oral use Initial U.S. Approval: 2012 | Product name | Dr. Reddy's Laboratories, Inc. | 2026-07-13 |
| Drug Facts | Product name | Dr. Reddy's Laboratories Inc. | Quality Packaging Specialists International, LLC | 2026-07-09 |
| Drug Facts | Product name | WALMART INC. (see also Equate) | 2026-07-09 |
| These highlights do not include all the information needed to use AMOXICILLIN TABLETS, AMOXICILLIN FOR ORAL SUSPENSION, AMOXICILLIN TABLETS (CHEWABLE), and AMOXICILLIN CAPSULES, safely and effectively. See full prescribing information for AMOXICILLIN TABLETS, AMOXICILLIN FOR ORAL SUSPENSION, AMOXICILLIN TABLETS (CHEWABLE), and AMOXICILLIN CAPSULES. AMOXICILLIN tablets, for oral use AMOXICILLIN for oral suspension, AMOXICILLIN tablets (chewable), for oral use AMOXICILLIN capsules, for oral use Initial U.S. A | Product name | Northwind Health Company, LLC | 2026-07-09 |
| These highlights do not include all the information needed to use LISINOPRIL TABLETS safely and effectively. See full prescribing information for LISINOPRIL TABLETS LISINOPRIL tablets, for oral use Initial U.S. Approval: 1988 | Product name | REMEDYREPACK INC. | 2026-07-08 |
| These highlights do not include all the information needed to use BUPRENORPHINE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE SUBLINGUAL TABLETS. BUPRENORPHINE Sublingual Tablets, for sublingual administration CIII Initial U.S. Approval: 2002 | Product name | REMEDYREPACK INC. | 2026-07-07 |
| These highlights do not include all the information needed to use ONDANSETRON ORALLY DISINTEGRATING TABLETS, safely and effectively. See full prescribing information for ONDANSETRON ORALLY DISINTEGRATING TABLETS. ONDANSETRON orally disintegrating tablets Initial U.S. Approval: 1991 | Product name | REMEDYREPACK INC. | 2026-07-07 |
| These highlights do not include all the information needed to use RINVOQ / RINVOQ LQ safely and effectively. See full prescribing information for RINVOQ / RINVOQ LQ . RINVOQ ® (upadacitinib) extended-release tablets, for oral use RINVOQ ® LQ (upadacitinib) oral solution Initial U.S. Approval: 2019 | Product name | AbbVie Inc. | 2026-06-30 |